News
April 28, 2023
Phapros recorded 8.9% growth for its ethical products in the first quarter of 2023.
Phapros CEO, Hadi Kardoko, stated that the growth of Phapros' branded prescription drugs (ethical products) in the first quarter of 2023 increased by 8.9% compared to the previous year....
See MoreApril 11, 2023
Welcoming the 2023 Eid al-Fitr Homecoming, Phapros Prepares Tens of Thousands of Product Packages and Antimo Posts
PT Phapros Tbk is preparing various programs to enliven the 2023 Eid al-Fitr homecoming moment with its legendary product, Antimo....
See MoreMarch 29, 2023
Current Year's Profit of PEHA Increases Significantly by 143 Percent, Analysts Evaluate Its Stock as Prospective.
PEHA recorded a sales growth of 11 percent and a significant current year's profit increase of 143 percent....
See MoreMarch 02, 2023
Indonesia has the potential to become the largest producer of herbal medicine, and Phapros supports the development of phytopharmaceuticals.
erbal products are one of Indonesia's comparative advantages, both in terms of raw materials and cultural heritage....
See MoreFebruary 17, 2023
Phapros' exports target to reach 15 percent penetration in 2023, Economist: Investor Confidence Could Increase
The value of pharmaceutical product exports from the state-owned pharmaceutical holding company, PT Phapros Tbk, is targeted to grow in double digits. ...
See MoreJanuary 26, 2023
Bone and Teeth Medical Devices Market Future Opportunity in Indonesia and ASEAN
PT Phapros Tbk melihat kebutuhan masyarakat akan operasi implantasi pada tulang dan gigi akibat kecelakaan cukup tinggi....
See More